MIRAGEN THERAPEUTICS, INC. 4
4 · MIRAGEN THERAPEUTICS, INC. · Filed Feb 16, 2017
Insider Transaction Report
Form 4
Marshall William Stuart
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2017-02-16+200,000→ 200,000 totalExercise: $11.01Exp: 2027-02-15→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant.